RT Journal Article
SR Electronic
T1 Statin myopathy: A common dilemma not reflected in clinical trials
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 393
OP 403
DO 10.3949/ccjm.78a.10073
VO 78
IS 6
A1 Genaro Fernandez
A1 Erica S. Spatz
A1 Charles Jablecki
A1 Paul S. Phillips
YR 2011
UL http://www.ccjm.org/content/78/6/393.abstract
AB Although statins are remarkably effective, they are still underprescribed because of concerns about muscle toxicity. We review the aspects of statin myopathy that are important to the primary care physician and provide a guide for evaluating patients on statins who present with muscle complaints. We outline the differential diagnosis, the risks and benefits of statin therapy in patients with possible toxicity, and the subsequent treatment options.